Phase 1 Parkinson’s Disease Studies Show the Dopamine D1/D5 Agonist PF-06649751 is Safe and Well Tolerated

por Sohur, U. Shivraj, Gray, David L., Duvvuri, Sridhar, Zhang, Yao, Thayer, Kathleen, Feng, Gang
Publicado 2018